| Code | Description | Claims | Beneficiaries | Total Paid |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
82,602 |
77,647 |
$10.05M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
92,951 |
86,410 |
$7.85M |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
10,710 |
6,598 |
$1.38M |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
3,790 |
3,672 |
$773K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
29,915 |
29,596 |
$771K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
6,115 |
5,253 |
$710K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
5,439 |
5,373 |
$709K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
6,347 |
3,844 |
$595K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
4,550 |
4,492 |
$591K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
6,125 |
6,116 |
$576K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
2,868 |
2,864 |
$445K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
6,330 |
3,297 |
$386K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
4,135 |
4,134 |
$377K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
4,418 |
4,259 |
$376K |
| S9083 |
Global fee urgent care centers |
2,429 |
2,301 |
$361K |
| 76830 |
Ultrasound, transvaginal |
2,717 |
2,712 |
$351K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
11,591 |
11,584 |
$336K |
| 76811 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed |
1,394 |
1,392 |
$279K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
2,508 |
2,506 |
$260K |
| 76820 |
|
5,176 |
3,119 |
$240K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
1,667 |
1,644 |
$232K |
| 76801 |
|
1,639 |
1,597 |
$222K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
4,112 |
4,077 |
$169K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
4,101 |
4,067 |
$168K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
1,798 |
1,768 |
$161K |
| 76813 |
|
1,191 |
1,186 |
$149K |
| 99215 |
Prolong outpt/office vis |
832 |
791 |
$148K |
| 59400 |
Routine obstetric care including antepartum care, vaginal delivery, and postpartum care |
45 |
45 |
$143K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
624 |
618 |
$141K |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
1,095 |
1,082 |
$136K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
1,289 |
1,160 |
$134K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
445 |
426 |
$134K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
912 |
895 |
$132K |
| 76536 |
|
1,054 |
1,051 |
$132K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
1,205 |
1,126 |
$126K |
| 80053 |
Comprehensive metabolic panel |
10,294 |
9,956 |
$119K |
| 90834 |
Psychotherapy, 45 minutes with patient |
1,609 |
1,062 |
$116K |
| 84443 |
Thyroid stimulating hormone (TSH) |
6,426 |
6,387 |
$114K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
1,228 |
1,228 |
$110K |
| 87481 |
|
1,432 |
1,346 |
$105K |
| 80061 |
Lipid panel |
7,118 |
7,091 |
$102K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
1,134 |
435 |
$98K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
11,504 |
10,645 |
$97K |
| 95004 |
Percutaneous tests with allergenic extracts, immediate type reaction |
428 |
374 |
$97K |
| 36415 |
Collection of venous blood by venipuncture |
36,419 |
34,257 |
$96K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
2,598 |
2,596 |
$94K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,096 |
1,083 |
$85K |
| 99223 |
Prolong inpt eval add15 m |
354 |
295 |
$84K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
1,975 |
1,946 |
$78K |
| 71046 |
Radiologic examination, chest; 2 views |
2,211 |
2,205 |
$78K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
881 |
567 |
$78K |
| J0585 |
Injection, onabotulinumtoxina, 1 unit |
55 |
55 |
$77K |
| 92551 |
|
7,151 |
7,145 |
$69K |
| 80050 |
General health panel |
1,493 |
1,491 |
$68K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,325 |
2,288 |
$66K |
| 90461 |
|
2,404 |
2,390 |
$63K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
6,208 |
6,201 |
$60K |
| 99205 |
Prolong outpt/office vis |
210 |
205 |
$58K |
| 88141 |
|
1,941 |
1,940 |
$56K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
195 |
194 |
$54K |
| 99222 |
Initial hospital care, per day, moderate complexity |
304 |
246 |
$53K |
| 20610 |
|
748 |
708 |
$53K |
| 97799 |
|
824 |
361 |
$53K |
| 99233 |
Prolong inpt eval add15 m |
391 |
206 |
$52K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
3,494 |
3,424 |
$51K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
922 |
904 |
$50K |
| 87631 |
|
314 |
313 |
$50K |
| 92134 |
|
1,086 |
1,068 |
$48K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
5,353 |
5,067 |
$46K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
385 |
384 |
$46K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
160 |
160 |
$43K |
| A4550 |
Surgical trays |
98 |
97 |
$43K |
| Q0091 |
Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory |
954 |
954 |
$42K |
| 99385 |
|
249 |
247 |
$42K |
| 59510 |
|
13 |
12 |
$42K |
| 93000 |
|
1,983 |
1,960 |
$40K |
| 88342 |
|
305 |
277 |
$40K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
1,146 |
1,146 |
$38K |
| 76641 |
|
224 |
214 |
$36K |
| 90686 |
|
10,197 |
10,188 |
$35K |
| 96127 |
|
6,190 |
6,167 |
$34K |
| 73562 |
|
730 |
694 |
$33K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
319 |
149 |
$32K |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
1,639 |
1,595 |
$31K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
100 |
100 |
$31K |
| 73630 |
|
775 |
729 |
$30K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
2,630 |
2,610 |
$30K |
| 95117 |
|
2,012 |
886 |
$28K |
| 99386 |
|
139 |
139 |
$28K |
| 87070 |
|
2,436 |
2,381 |
$27K |
| 73221 |
|
84 |
83 |
$26K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,030 |
832 |
$25K |
| 99239 |
Hospital discharge day management, more than 30 minutes |
192 |
187 |
$24K |
| 99459 |
|
776 |
765 |
$23K |
| 82607 |
|
1,200 |
1,194 |
$22K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
247 |
245 |
$21K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
617 |
612 |
$21K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
42 |
42 |
$21K |
| 92012 |
Ophthalmological services: medical examination and evaluation, intermediate, established patient |
195 |
179 |
$21K |
| 20553 |
|
307 |
289 |
$20K |
| 59025 |
Fetal non-stress test |
285 |
174 |
$19K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
1,555 |
1,480 |
$17K |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
24 |
24 |
$17K |
| 0011A |
|
505 |
505 |
$17K |
| 92004 |
Ophthalmological services: medical examination and evaluation, comprehensive, new patient |
94 |
94 |
$17K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
39 |
39 |
$16K |
| 0012A |
|
432 |
432 |
$16K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
107 |
107 |
$15K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
307 |
270 |
$15K |
| 73610 |
|
392 |
369 |
$15K |
| 92133 |
|
320 |
319 |
$14K |
| 82728 |
|
834 |
822 |
$14K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
1,328 |
1,275 |
$13K |
| 87634 |
|
185 |
180 |
$13K |
| 99221 |
|
138 |
132 |
$13K |
| 72141 |
|
54 |
54 |
$13K |
| 59514 |
|
15 |
14 |
$12K |
| 97161 |
|
153 |
152 |
$12K |
| 81025 |
|
1,349 |
1,309 |
$11K |
| 92020 |
|
339 |
339 |
$11K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
1,107 |
1,089 |
$11K |
| 82746 |
|
602 |
599 |
$11K |
| 95953 |
|
18 |
12 |
$11K |
| 95806 |
|
53 |
52 |
$10K |
| 73030 |
|
287 |
282 |
$10K |
| 84439 |
|
868 |
857 |
$10K |
| 90715 |
|
381 |
381 |
$10K |
| 93015 |
|
102 |
101 |
$10K |
| 99070 |
|
14 |
13 |
$10K |
| 99173 |
|
2,254 |
2,245 |
$10K |
| 97802 |
|
84 |
84 |
$9K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
861 |
856 |
$8K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
27 |
27 |
$8K |
| 87660 |
|
313 |
311 |
$8K |
| 87510 |
|
313 |
311 |
$8K |
| 87480 |
|
313 |
311 |
$8K |
| 99460 |
|
65 |
65 |
$8K |
| 73110 |
|
185 |
171 |
$8K |
| 58300 |
|
77 |
77 |
$7K |
| 96160 |
|
2,987 |
2,976 |
$7K |
| 95886 |
|
68 |
52 |
$7K |
| 81513 |
|
55 |
55 |
$7K |
| 73130 |
|
184 |
170 |
$7K |
| 86140 |
|
1,073 |
1,063 |
$7K |
| 83655 |
|
476 |
475 |
$7K |
| 83550 |
|
653 |
648 |
$7K |
| J2916 |
Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg |
105 |
36 |
$7K |
| 92557 |
|
153 |
153 |
$7K |
| 93224 |
|
56 |
56 |
$7K |
| 87077 |
|
518 |
503 |
$6K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
407 |
400 |
$6K |
| 67028 |
Intravitreal injection of a pharmacologic agent |
50 |
37 |
$6K |
| 64615 |
|
29 |
29 |
$6K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
248 |
234 |
$6K |
| 86618 |
|
280 |
277 |
$6K |
| 72110 |
|
113 |
113 |
$6K |
| 86762 |
|
327 |
327 |
$6K |
| 90661 |
|
1,727 |
1,727 |
$6K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
13 |
13 |
$5K |
| 99381 |
|
43 |
43 |
$5K |
| 90651 |
|
422 |
422 |
$5K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
27 |
27 |
$5K |
| 83540 |
|
653 |
648 |
$5K |
| 86803 |
|
310 |
310 |
$5K |
| 92235 |
|
36 |
36 |
$5K |
| 85027 |
|
602 |
597 |
$5K |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
28 |
28 |
$4K |
| 86787 |
|
284 |
284 |
$4K |
| 58301 |
|
35 |
35 |
$4K |
| 87420 |
|
322 |
311 |
$4K |
| 82043 |
|
609 |
605 |
$4K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
125 |
91 |
$4K |
| 90670 |
|
1,551 |
1,550 |
$4K |
| 84702 |
|
222 |
169 |
$4K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
20 |
12 |
$4K |
| 81003 |
|
1,575 |
1,539 |
$4K |
| 92567 |
|
218 |
217 |
$4K |
| 82570 |
|
613 |
609 |
$4K |
| 93351 |
|
12 |
12 |
$4K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
48 |
48 |
$4K |
| 85652 |
|
1,114 |
1,105 |
$4K |
| 73502 |
|
81 |
80 |
$4K |
| 72100 |
|
91 |
91 |
$4K |
| 87150 |
|
83 |
83 |
$4K |
| 85018 |
|
1,276 |
1,270 |
$4K |
| 99462 |
|
69 |
53 |
$3K |
| 70450 |
Computed tomography, head or brain; without contrast material |
24 |
24 |
$3K |
| 87186 |
|
307 |
296 |
$3K |
| 88142 |
|
136 |
136 |
$3K |
| 0064A |
|
118 |
118 |
$3K |
| 83001 |
|
141 |
141 |
$3K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
64 |
64 |
$3K |
| J2785 |
Injection, regadenoson, 0.1 mg |
13 |
13 |
$3K |
| 94729 |
|
42 |
42 |
$3K |
| 17110 |
|
27 |
27 |
$3K |
| 93970 |
|
12 |
12 |
$3K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
94 |
53 |
$3K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
320 |
317 |
$3K |
| 84460 |
|
427 |
423 |
$3K |
| 99188 |
|
183 |
183 |
$3K |
| A9585 |
Injection, gadobutrol, 0.1 ml |
85 |
72 |
$3K |
| 31231 |
|
12 |
12 |
$3K |
| 84153 |
|
108 |
108 |
$2K |
| G2012 |
Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion |
133 |
129 |
$2K |
| 84450 |
|
408 |
405 |
$2K |
| 84146 |
|
97 |
97 |
$2K |
| 82670 |
|
63 |
63 |
$2K |
| 0031A |
|
57 |
57 |
$2K |
| 94726 |
|
27 |
27 |
$2K |
| 72040 |
|
57 |
56 |
$2K |
| 85610 |
|
399 |
318 |
$2K |
| 86580 |
|
206 |
190 |
$2K |
| 73140 |
|
55 |
51 |
$2K |
| 99406 |
|
112 |
111 |
$2K |
| 86376 |
|
101 |
101 |
$2K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
19 |
19 |
$2K |
| 90707 |
|
759 |
756 |
$2K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
18 |
18 |
$2K |
| 83002 |
|
78 |
77 |
$2K |
| 77065 |
Tomosynthesis, mammo |
12 |
12 |
$2K |
| 20611 |
|
13 |
12 |
$2K |
| 84481 |
|
78 |
78 |
$2K |
| 86703 |
|
96 |
96 |
$2K |
| 94010 |
|
34 |
33 |
$2K |
| 93298 |
|
15 |
15 |
$2K |
| 83735 |
|
190 |
173 |
$1K |
| 82550 |
|
178 |
175 |
$1K |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
333 |
233 |
$1K |
| 99242 |
|
12 |
12 |
$1K |
| 82247 |
|
249 |
232 |
$1K |
| 99441 |
|
18 |
18 |
$1K |
| 87071 |
|
120 |
119 |
$1K |
| 82950 |
|
223 |
223 |
$1K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
232 |
222 |
$1K |
| 83690 |
|
150 |
150 |
$1K |
| 99217 |
|
13 |
13 |
$1K |
| 84075 |
|
210 |
207 |
$1K |
| 92083 |
|
15 |
15 |
$1K |
| 81001 |
|
299 |
290 |
$1K |
| 82150 |
|
141 |
141 |
$1K |
| 85730 |
|
146 |
144 |
$1K |
| 94060 |
|
13 |
13 |
$1K |
| 77080 |
|
26 |
26 |
$1K |
| 84466 |
|
78 |
78 |
$1K |
| 90734 |
|
337 |
337 |
$1K |
| 98925 |
|
28 |
27 |
$1K |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
71 |
66 |
$989.60 |
| 69210 |
|
12 |
12 |
$967.35 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
43 |
39 |
$966.97 |
| 86431 |
|
138 |
138 |
$966.00 |
| 86765 |
|
61 |
61 |
$964.95 |
| 86735 |
|
59 |
59 |
$926.25 |
| 0071A |
|
41 |
41 |
$800.00 |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
16 |
15 |
$766.91 |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
27 |
27 |
$650.16 |
| 99442 |
|
12 |
12 |
$643.76 |
| 86800 |
|
29 |
29 |
$624.90 |
| 73080 |
|
17 |
12 |
$580.21 |
| 84550 |
|
103 |
100 |
$574.74 |
| 81002 |
|
151 |
145 |
$515.04 |
| 90716 |
|
321 |
321 |
$497.32 |
| 82951 |
|
28 |
28 |
$444.92 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
40 |
40 |
$430.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
26 |
26 |
$405.60 |
| 0002A |
|
12 |
12 |
$390.85 |
| 86780 |
|
29 |
29 |
$383.96 |
| 86160 |
|
13 |
13 |
$370.25 |
| 0072A |
|
18 |
18 |
$360.00 |
| 90697 |
|
71 |
71 |
$306.20 |
| 83615 |
|
41 |
41 |
$305.45 |
| 90677 |
|
170 |
170 |
$266.70 |
| 0001A |
|
23 |
23 |
$264.31 |
| 87340 |
|
25 |
25 |
$258.25 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
134 |
127 |
$256.68 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
182 |
178 |
$252.45 |
| 99000 |
|
1,504 |
1,466 |
$210.00 |
| 80047 |
|
13 |
12 |
$178.49 |
| 96040 |
|
12 |
12 |
$158.73 |
| 36416 |
|
1,467 |
1,414 |
$141.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
91 |
71 |
$137.13 |
| 87205 |
|
26 |
26 |
$135.15 |
| 3078F |
|
3,544 |
3,445 |
$120.00 |
| 3074F |
|
5,021 |
4,884 |
$100.00 |
| 82962 |
|
31 |
29 |
$94.87 |
| 82565 |
|
14 |
14 |
$88.62 |
| 85045 |
|
13 |
13 |
$64.09 |
| 84520 |
|
13 |
13 |
$63.44 |
| 85007 |
|
26 |
26 |
$59.36 |
| 82040 |
|
14 |
12 |
$29.70 |
| 90633 |
|
503 |
503 |
$24.00 |
| 90744 |
|
322 |
322 |
$23.38 |
| 84155 |
|
14 |
12 |
$18.35 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
12 |
12 |
$7.02 |
| 94761 |
|
18 |
16 |
$6.58 |
| 97010 |
|
223 |
105 |
$4.50 |
| 91306 |
|
115 |
115 |
$0.20 |
| 91301 |
|
897 |
880 |
$0.12 |
| 90648 |
|
64 |
64 |
$0.00 |
| 90700 |
|
87 |
87 |
$0.00 |
| 90685 |
|
437 |
437 |
$0.00 |
| 3077F |
|
217 |
209 |
$0.00 |
| J1050 |
Injection, medroxyprogesterone acetate, 1 mg |
32 |
32 |
$0.00 |
| 91300 |
|
33 |
27 |
$0.00 |
| 3051F |
|
12 |
12 |
$0.00 |
| 3079F |
|
850 |
832 |
$0.00 |
| 90698 |
|
734 |
734 |
$0.00 |
| 91303 |
|
46 |
46 |
$0.00 |
| 90680 |
|
551 |
551 |
$0.00 |
| 90656 |
|
51 |
51 |
$0.00 |
| 90696 |
|
99 |
99 |
$0.00 |
| 3044F |
|
394 |
394 |
$0.00 |
| 3080F |
|
92 |
91 |
$0.00 |
| 90619 |
|
130 |
130 |
$0.00 |
| 91307 |
|
71 |
59 |
$0.00 |
| 3075F |
|
299 |
295 |
$0.00 |
| 2023F |
|
17 |
17 |
$0.00 |